Volume 23 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
SU Afang, LI Guangjian, ZHANG Yunshui, WU Shouling, JIANG Xiaozhong. Study on the association between the Chinese visceral adiposity index and the risk of acute pancreatitis[J]. Chinese Journal of General Practice, 2025, 23(11): 1878-1881. doi: 10.16766/j.cnki.issn.1674-4152.004250
Citation: SU Afang, LI Guangjian, ZHANG Yunshui, WU Shouling, JIANG Xiaozhong. Study on the association between the Chinese visceral adiposity index and the risk of acute pancreatitis[J]. Chinese Journal of General Practice, 2025, 23(11): 1878-1881. doi: 10.16766/j.cnki.issn.1674-4152.004250

Study on the association between the Chinese visceral adiposity index and the risk of acute pancreatitis

doi: 10.16766/j.cnki.issn.1674-4152.004250
Funds:

 20221582

  • Received Date: 2024-10-19
    Available Online: 2026-01-07
  •   Objective  Visceral fat is mostly related to metabolic disorders. This study aimed to explore the relationship between the chinese visceral adiposity index (CVAI) in the Chinese population and the risk of acute pancreatitis (AP).  Methods  A total of 123 461 eligible participants from the Kailuan cohort who participated their first physical examination between 2006 and 2009 were included. Participants were divided into four groups according to the CVAI quartile level. Group Q1 (31 015 cases, CVAI≤7.07 mmol/L), Group Q2 (30 817 cases, 7.07 mmol/L < CVAI≤38.92 mmol/L), Group Q3 (30 816 cases, 38.92 mmol/L < CVAI≤70.74 mmol/L), and Group Q4 (30 813 cases, CVAI>70.74 mmol/L). The cumulative incidence of AP was calculated by Kaplan-Meier method and compared across groups with the log-rank. Multivariate Cox proportional hazard regression model was applied to analyze the evaluated the association between CVAI quartiles and incident AP during follow-up.  Results  Over a mean followed up period of (13.71±2.65) years, 418 cases of AP were identified among 123 416 participants. There were significant differences in the cumulative incidence of AP were observed among the four CVAI quartile groups (χ2=8.862, P=0.031). Multivariate analysis showed that participants in the Q4 group had a significantly high risk of AP (HR=1.504, 95% CI: 1.126-2.010, P=0.006) compared to the Q1 group. In males, the HR (95% CI) for AP in the Q4 group was 1.368 (95% CI: 1.007-1.858, P=0.045). After excluding AP cases that occurred within 2 years of follow-up, the association remained significant (HR=1.553, 95% CI: 1.141-2.112, P=0.005).  Conclusion  Higher CVAI are associated with an increased risk of acute pancreatitis. CVAI may serve as an effective indicator for identifying individuals at elevated risk of AP disease.

     

  • loading
  • [1]
    PETROV M S, YADAV D. Global epidemiology and holistic prevention of pancreatitis[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(3): 175-184. doi: 10.1038/s41575-018-0087-5
    [2]
    HANSEN S E J, MADSEN C M, VARBO A, et al. Body mass index, triglycerides, and risk of acute pancreatitis: a population-based study of 118 000 individuals[J]. J Clin Endocrinol Metab, 2020, 105(1): 163-174. doi: 10.1210/clinem/dgz059
    [3]
    中国居民营养与慢性病状况报告(2020年)[J]. 营养学报, 2020, 42(6): 521.

    Report on the Nutrition and Chronic Diseases Status of Chinese Residents 2020[J]. Acta Nutrimenta Sinica, 2020, 42(6): 521.
    [4]
    XIA M F, CHEN Y, LIN H D, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese[J]. Sci Rep, 2016, 6: 38214. DOI: 10.1038/srep38214.
    [5]
    WU S L, HUANG Z R, YANG X C, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city[J]. Circ Cardiovasc Qual Outcomes, 2012, 5(4): 487-493. doi: 10.1161/CIRCOUTCOMES.111.963694
    [6]
    中华医学会消化病学分会胰腺疾病学组, 《中华胰腺病杂志》编辑委员会, 《中华消化杂志》编辑委员会. 中国急性胰腺炎诊治指南(2019, 沈阳)[J]. 中华胰腺病杂志, 2019, 19(5): 321-331.

    Pancreatic Disease Group, Gastroenterology Branch of the Chinese Medical Association, Editorial Committee of "Chinese Journal of Pancreatic Diseases", Editorial Committee of "Chinese Journal of Gastroenterology". Diagnosis and Treatment Guidelines for Acute Pancreatitis in China (2019, Shenyang)[J]. Chinese Journal of Pancreatology, 2019, 19(5): 321-331.
    [7]
    WEI Z X, HUA J Y, YING B H, et al. The visceral adiposity index predicts the severity of hyperlipidaemic acute pancreatitis[J]. Intern Emerg Med, 2022, 17(2): 417-422. doi: 10.1007/s11739-021-02819-4
    [8]
    DOBSZAI D, MATRAI P, GYONGYI Z, et al. Body-mass index correlates withseverity and mortality in acute pancreatitis: a meta-analysis[J]. World J Gastroenterol, 2019, 25(6): 729-743. doi: 10.3748/wjg.v25.i6.729
    [9]
    KRISHNA S G, HINTON A, OZA V, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched study[J]. Am J Gastroenterol, 2015, 110(11): 1608-1619. doi: 10.1038/ajg.2015.343
    [10]
    MCAULEY P A, BLAIR S N. Obesity paradoxes[J]. Sports Sci, 2011, 29(8): 773-782. doi: 10.1080/02640414.2011.553965
    [11]
    DUARTE-ROJO A, SOSA-LOZANO L A, SAUL Á, et al. Methods for measuring abdominal obesity in the prediction of severe acute pancreatitis, and their correlation with abdominal fat areas assessed by computed tomography[J]. Aliment Pharmacol Ther, 2010, 32(2): 244-253. doi: 10.1111/j.1365-2036.2010.04321.x
    [12]
    HAN M H, QIN P, LI Q M, et al. Chinese visceral adiposity index: a reliable indicator of visceral fat function associated with risk of type 2 diabetes[J]. Diabetes Metab Res Rev, 2021, 37(2): e3370. DOI: 10.1002/dmrr.3370.
    [13]
    HAN M H, QIE R R, LIU L M, et al. Chinese visceral adiposity index, a novel inditor of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study[J]. Br J Nutr, 2021, 126(4): 612-620. doi: 10.1017/S0007114520004298
    [14]
    YANG Y M, WANG B M, YUAN H Y, et al. Triglycerides to high-density lipoprotencholesterol ratio is the best surrogate marker for insulin resistancein nonobese middle-aged and elderly population: a cross-sectional study[J]. Int J Endocrinol, 2021: 6676569. DOI: 10.1155/2021/6676569.
    [15]
    MILIC S, LULIC D, STMAC D. Non-alcoholic fatty liver disease and obesity: biochemical metabolic and clinical presentations[J]. World J Gastroenterol, 2014, 20(28): 9330-9337. doi: 10.3748/wjg.v20.i28.9330
    [16]
    程峰, 邱兆磊, 郑传明, 等. JAK/STAT信号通路在大鼠重症急性胰腺炎早期作用机制的研究[J]. 中华全科医学, 2023, 21(1): 41-44, 65. doi: 10.16766/j.cnki.issn.1674-4152.002807

    CHENG F, QIU Z L, ZHENG C M, et al. Mechanism of JAK/STAT signaling pathway in the early stage severe acute pancreatitis rats[J]. Chinese Journal of General Practice, 2023, 21(1): 41-44, 65. doi: 10.16766/j.cnki.issn.1674-4152.002807
    [17]
    JUNIOR G B S, BENTES A C, DAHER E F, et al. Obesity and kidney disease[J]. J Bras Nefrol, 2017, 39(1): 65-69.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Article Metrics

    Article views (31) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return